Posted By Elaine Lok CRA,
Tuesday, July 8, 2014
Updated: Wednesday, June 25, 2014
| Comments (0)
Course Spotlight: Unraveling Angiogenesis and Anti-VegF
Lecturer: Muge Kesen, MD
Date: Friday, October 17, 2014 @ 10:45AM
Ocular angiogenesis, also known as neovascularization, is responsible for the majority of irreversible blindness in the developed world. A diverse group of diseases affecting different age populations such as diabetic retinopathy, age-related macular degeneration (AMD), neovascular glaucoma, and retinopathy of prematurity (ROP) are among those that are associated with this serious complication.
Dr. Judah Folkman’s concept of angiogenesis was initially criticized by the biomedical research community; however, his continued work over the years paid dividends for us all, as he eventually proved his theory to be true and valid. Until anti-vascular endothelial growth factor (VEGF) treatments became available, destructive laser procedures were the only options against some forms of ocular neovascularization. In these and other disorders, researchers now try to block angiogenesis with the ultimate attempt to preserve vision.
Arguably, one of the most critical responsibilities of the ophthalmic photographer is to locate and photograph neovascularization using various imaging modalities; failure to capture these abnormal blood vessels may result in delayed treatment and affect the visual outcomes. Upon completion of this course, the attendee will have a better understanding of angiogenesis, vascular endothelial growth factor (VEGF), anti-VEGF treatments used in ophthalmology, and the critical role the ophthalmic photographer plays in preserving vision for our patients.
This post has not been tagged.